Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(3R,4R)-1-{6-[3-(methylsulfonyl)phenyl]pyrimidin-4-yl}-4-(2,4,5-trifluorophenyl)piperidin-3-amine
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule belonging to the phenylpyrimidine class. It features a piperidine core substituted with a trifluorophenyl group and a pyrimidin ring bearing a methylsulfonylaniline moiety. The compound is listed in chemical and pharmaceutical databases as an experimental agent but has not been approved for any therapeutic use. There are no reported clinical trials or approved indications for this molecule. Its mechanism of action and biological targets have not been clearly established in public sources[1][2]. It appears primarily in research contexts as a screening or reference compound.
- Other names
- (3r,4r)-1-{6-[3-(methylsulfonyl)phenyl]pyrimidin-4-Yl}-4-(2,4,5-trifluorophenyl)piperidin-3-Amine(3R,4R)-1-[6-(3-methanesulfonylphenyl)pyrimidin-4-yl]-4-(2,4,5-trifluorophenyl)piperidin-3-amine
02
Targets
DPP9 (Dipeptidyl Peptidase 9)DPP8 (Dipeptidyl peptidase 8)
Beyond the preview
Go deeper on (3R,4R)-1-{6-[3-(methylsulfonyl)phenyl]pyrimidin-4-yl}-4-(2,4,5-trifluorophenyl)piperidin-3-amine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (3R,4R)-1-{6-[3-(methylsulfonyl)phenyl]pyrimidin-4-yl}-4-(2,4,5-trifluorophenyl)piperidin-3-amine.